Studies have reported that the low expression of SEMA6A-AS1 in hepatocellular carcinoma is associated with the poor prognosis of HBV-associated hepatocellular carcinoma (Yu et al., 2020). The gene discussed is SEMA6A; the disease is hepatocellular carcinoma.